Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Volcano Corporation Presentation At Conference To Be Webcast

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 17, 2014 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today…

OncoSec Medical Inc. And Plexxikon Inc. Collaborate To Explore Combination Immunotherapy In Preclinical Tumor Studies

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced a preclinical collaboration with Plexxikon Inc., a member of the Daiichi Sankyo Group and leader in the discovery and development of novel small molecule pharmaceuticals, to test the combination of Plexxikons selective CSF-1R inhibitor with OncoSecs Immunopulse…

International Stem Cell Corporation To Present Preclinical Parkinson’s Disease Data At

November 17, 2014 – 5:00 pm | Edit Post

Safety and Efficacy Data From Company’s Human Neural Stem Cells Featured in Neuroscience 2014 Press Program “Advances Through Stem Cell Research” CARLSBAD, CA–(November 18, 2014) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today preclinical data from its Parkinson…

New Study Shows How ZMapp Binds to Ebola, Ways to Boost Potency

November 17, 2014 – 2:18 pm | Edit Post

Scientists at The Scripps Research Institute have produced the first 3-D image of how the ZMapp drug developed by San Diego’s Mapp Biopharmaceutical binds to the Ebola virus, providing new insights…
[[Click headline to continue reading.]]

Anti-Leukemia Drug May Also Work Against Ovarian Cancer

November 17, 2014 – 1:00 pm | Edit Post

An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well, report researchers at the University of California, San Diego School of Medicine.

Triclosan may cause liver cancer

November 17, 2014 – 1:00 pm | Edit Post

Antibacterial agent causes cancer in mice; mechanism may apply to people.

The Dirty Side of Soap

November 17, 2014 – 1:00 pm | Edit Post

Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.

NCI-Designated Cancer Center hosts successful second open house

November 17, 2014 – 10:30 am | Edit Post

Sanford-Burnham’s NCI-Designated Cancer Center and the Cancer Center’s Community Advisory Board hosted the second Cancer Center open house for cancer survivors, their families and friends, and research advocates on Thursday, November 6, in La Jolla, Calif.

New Research Could (Finally) Remove RNAi’s Commercial Limitations

November 17, 2014 – 9:05 am | Edit Post

[Corrected 11/17/14, 12:30pm. See below.] If nothing else, the acronym RNAi, which stands for ribonucleic acid interference, should be familiar to biotech observers as something that won two…

[[Click headline to continue reading.]]

Chemical Disguise Transforms RNAi Drug Delivery

November 17, 2014 – 9:00 am | Edit Post

Researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors — called siRNNs — into active RNAi drugs.